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Clinically insigniﬁcant residual fragments (CIRFs) are small fragments (less than 5mm) that are present in upper urinary tract at
the time of regular post-SWL followup. The term is controversial because they may remain silent and asymptomatic or become
a risk factor for stone growth and recurrence, leading to symptomatic events, and need further urologic treatment. Although a
stone-free state is the desired outcome of surgical treatment of urolithiasis, the authors believe that the presence of noninfected,
nonobstructive, asymptomatic residual fragments can be managed metabolically in order to prevent stone growth and recurrence.
Further urologic intervention is warranted if clinical indications for stone removal are present.
1.Introduction
With the introduction of shock wave lithotripsy (SWL) in
1980, the treatment of renal calculi was revolutionised. Few
medical innovations have had the dramatic eﬀect of SWL
which quickly became the treatment of choice for most
upper-tract calculi [1]. However, as our approach to the
treatment of urinary calculi has changed, so has our concept
of what constitutes successful treatment. When open surgery
was the standard treatment for the management of renal
calculi, the presence of residual stones suggested a failed
procedure, even if those remaining stones were small [2].
SWLdoesnotremovestones;itdisintegratesthemproducing
fragments which must be passively excreted. However, the
clearance of the fragments produced by shock waves is not
immediatesinceasmanyas85%ofpatientshaveradiological
evidence of residual fragments when discharged from hospi-
tal [3] .T h er e s i d u a lf r a g m e n t sa r ed e ﬁ n e da sa l lf r a g m e n t s
remaining in the kidney 3 months after the last session of
SWL. Among these fragments, those larger than 5mm are
generally considered as failures of the SWL session. The
residual fragments with diameter less than 5mm that are
asymptomatic and noninfected are expected to pass sponta-
neously without further treatment, leading to the deﬁnition
of clinically insigniﬁcant residual fragments (CIRFs) [4]. In
case of persistence within the upper urinary tract, these frag-
ments may grow and gain clinical relevance again, becoming
symptomatic or requiring intervention [5].
This article paper the implications of residual fragments
after lithotripsy and suggests guidelines for their manage-
ment.
2. Incidence of ResidualFragments
Residual fragments are common after SWL. At the discharge,
fragments less than 5mm have been described in 85% to
96% of patients with calcium [3, 6] and in 92% with infected
stones [7]. The majority of these fragments will be passed
within a few weeks. With increasing renal persistence of re-
sidual fragments, the probability of stone clearance seems to
decrease [8].
In the absence of symptoms, most stone centers recom-
mended radiographic evaluation approximately 1 month af-
ter SWL and at varying intervals thereafter as deemed clini-
cally necessary. With such followup, studies of large numbers
of patients reveal that 24% to 36% will have residual frag-
ments up to 3 months after SWL [3, 6, 9, 10].
Clinical experience has been able to identify several pro-
gnostic factors that decrease the incidence of residual frag-
ments after SWL. Stone size (diameter more than 20mm),2 Advances in Urology
multiple stones, and stone composed primarily of cystine,
brushite, or calcium oxalate monohydrate are less likely to
be cleared completely after SWL and more likely associated
with residual fragments [11–14]. When congenital renal
anomalies (e.g., horseshoe, malrotated and duplex kidneys)
or distorted urinary tract are present, SWL could be the
treatment of choice when the stone size is less than 20mm.
Anterograde or retrograde ancillary procedures or multiple
SWL sessions could be required with consequent morbidity
and highest cost-eﬃciency, while anatomic anomalies do not
appear to have a signiﬁcant impact on stone-free rate if
percutaneous lithotripsy or more frequently ureteroscopy is
performed[15–20].Inthecaseoftransplantedkidneys,SWL
could be successfully performed only for small stones treat-
ing the patient in prone position with ultrasound targeting
[21, 22]. The clearance of fragments is, moreover, delayed
for lower pole renal calculi and certain spatial anatomic
factors, such as the infundibulopelvic angle, infundibular
length and width [17, 23, 24]. However, another study has
reported that the clearance of lower calyx stones could not
be inﬂuenced by collecting system anatomy [25]. Morbid
obesity, independent of previous factors, also impacts on
stone-clearance rates [14].
Taking these studies into account, evaluation of patients
prior to SWL is important, and the use of imaging in the
decision process can help to identify suitable patients for
shock wave treatment. More recently, nomograms and arti-
ﬁcial neural networks have been created in predicting the
outcome with the use of computed tomography attenuation
values and skin-to-stone distance. In addition, modiﬁcations
in shock wave delivery by altering shock wave rate and volt-
age and the use of expulsive and chemolytic treatment have
been researched in an eﬀort to improve shock wave efﬁcacy
[14, 26].
3. Diagnosisof ResidualFragments
While the presence of residual fragments is usually reported
asafunctionoftheﬁndingsonplainabdominalradiographs,
plain ﬁlms have signiﬁcant limitations.
The initial report that compared endoscopic and radi-
ological evaluation of residual fragments rates following
percutaneous nephrostolithotomy and SWL demonstrated
that plain abdominal radiographs and renal tomography
overestimated stone-free rates by 35% and 17%, respectively,
compared with ﬂexible nephroscopy [27]. Nephroscopy,
however, is routinely feasible postoperatively only in patients
who have undergone a percutaneous nephrostolithotomy
and still have a nephrostomy tube in place.
Given the limitations of plain ﬁlms, the true incidence
of residual stones is therefore probably higher than generally
reported. These facts result from superimposition of bowel
gas, feces, and soft-tissue calciﬁcations. As such, at least,
someofthereportedpost-SWLrecurrencesrepresentgrowth
of missed or nonradiologically visible residual fragments.
Some reports have suggested that tomograms detect more
stones than the original reported by plain ﬁlms. Jewett et al.
studied interobserver and intraobserver reduced variability
in assessing the presence of post-ESWL residual fragments
reading plain ﬁlms and tomography together [28].
Several reports have addressed the sensitivity of ultra-
sound in the detection of urolithiasis to be between 65% and
95% [29, 30]. The advantage of ultrasound relies on the fact
that all stones, independent of their composition, present an
acoustic-impedance mismatch with the surrounding tissues
and attenuate sound to a greater degree. However, ultra-
soundisinadequateinquantifyingthestoneburdenandgen-
erally does not permit diﬀerentiation on intact stones from
fragmented stones.
Nowdays,themostaccuratediagnostictesttoaddressthe
presence of residual fragments is noncontrast spiral CT that
have proved superior to plain radiography, linear tomog-
raphy and ultrasound in detecting postprocedural residual
fragments [31–34]. Spiral CT also was shown to have supe-
rior sensitivity and equal speciﬁcity to intravenous urogra-
phy in detecting renal stones and demonstrates equal sen-
sitivity in the detection of ureteral dilation and can detect
stoneofvariouscomposition.Therefore,ithasbeenreported
that selective use of ﬂexible nephroscopy after percutaneous
nephrostolithotomy based on positive CT ﬁnding will avoid
an unnecessary operation. Nephroscopy or ﬂexible ureteros-
copycouldbenecessaryifsecondlookforremovalofresidual
fragments has been planned [35].
4. Fate of Residual Stones
Residualfragmentsmaybeimportantforavarietyofreasons:
they may act as a nidus for recurrent stone growth, they can
become acutely dislodged and cause signiﬁcant obstruction
with pain and infection, or they may be the source of per-
sistent infection.
After stone fragmentation, the underlying metabolic ab-
normalities for recurrent stone formation persist. Supersatu-
ration of the urine with stone-forming salts or lack of stone
inhibitors may accelerate the growth of residual fragments
and promote new stone recurrence. Furthermore, it has been
reported that in the case of patients rendered stone-free
after SWL, stone-recurrence rate is higher than a similar
group treated by percutaneous nephrolithotomy, without
ultrasonic fragmentation [36]. Higher recurrences may be
causedbymicroscopicsandparticlesmigratingtodependent
calyces and acting as nidus for new stone formation. By
dramatically increasing the surface area of the original stone,
SWL may favour new stone growth through heterogeneous
nucleationandcrystalaggregationbyexposingthestonearea
to a lithogenic environment.
S e v e r a lg r o u p sh a v er e p o r t e ds t o n er e c u r r e n c ef r o ms u c h
fragments in varying percentages [4, 5, 8, 37–40]( Table 1).
Bucholz et al. [40]r e p o r t e dav e ryl o w( 2 % )r e g r o w t hr a t eo f
residual fragments at a mean followup of 2.5 years, while a
far higher 59% regrowth rate at a followup of 15 months was
published by Khaitan et al. [38].
A prospective study followed 160 patients with 4mm or
smaller asymptomatic calcium oxalate or calcium phosphate
stone fragments after SWL for a mean of 23 months. Overall
the fragment regrowth rate was 18.1%, while 41.9% ofAdvances in Urology 3
Table 1: Rate of regrowth of residual fragments.
Study (year) Followup (mos) Growth (%)
Streem et al., 1996 [37] 89 18.1
Zanetti et al., 1997 [39]2 4 1 7
Bucholz et al., 1997 [40]3 0 2 . 1
Candau et al., 2000 [4]4 0 3 7
Khaitan et al., 2002 [38]1 5 5 9
Osman et al., 2005 [8] 60 21.4
El-Nahas et al., 2006 [5] 31 13.6
fragments remained unchanged in size during long-term
followup. After 5 years, 36% of fragments had passed, and
the majority of these did so within the ﬁrst year after SWL.
Using Kaplan-Mayer estimates, the probability of fragments
passing, decreasing in number or remaining stable, was 80%
over 5 years. At followup, however, 43.1% of these patients
had developed signiﬁcant symptomatic episodes that needed
intervention when stone migrated to the ureter or increased
in size [37].
Historically, infection stones have required aggressive
extirpative management. The urea splitting bacteria neces-
sary for the formation of these stones may persist in the
residual fragments, thus promoting a cycle of persistent
infection and accelerated growth [41].
Sterilisation of residual infection stones is the goal stand-
ard of the treatment. While the role of long-term urease
inhibitors in this setting is unproven, we have observed at 12
months of followup the eﬀectiveness of prophylactic antibi-
otics not only on the clearance, but also on the growth and
aggregation of residual infection fragments after SWL [42].
5. Management of Residual Stones
Themanagementofresidualfragmentsiscontroversial,espe-
cially given the potential for these fragments to grow and
become clinically signiﬁcant.
With the goal of improving stone-free rate, several au-
thors have advocated early retreatment. Kring et al. retreated
patientswhoshowedresidualfragments2monthsafterSWL,
and 60% of these patients were subsequently rendered stone-
free [43]. Moon and Kim applied an additional session of
SWL to small (3-4mm) residual fragments present 1 month
after SWL and achieved a 92% stone-free rate at 6 months
[44]. However, although the complication rate is minimal,
patients are inconvenienced, and work days are lost.
More recently, Albanis et al. evaluated the eﬃcacy and
safety of forced hydration and diuresis with limited inversion
during shock wave lithotripsy in improving stone-free rate
for lower pole stone clearance. Followup at 3 months showed
that 83.3% of the patients belonging to the study group were
rendered stone-free, whereas 71.5% were stone-free in the
control group, without statically signiﬁcant diﬀerence [45].
Nowadays, the cost of medical procedures must be con-
sidered. Secondary treatment could be considered in symp-
tomatic, obstructive residual stones or in stone-associated
urinary tract infection. Treatment could also be considered
for asymptomatic residual stones in patients who cannot risk
an episode of kidney colic (e.g., airplane pilots) or urinary
tract infection (e.g., transplant patients). In these cases, ure-
teroscopy could be considered [19, 46].
In patients with nonobstructive, noninfected, asymp-
tomatic residual fragments, one might consider aggressive
medical therapy with the correction of underlying metabolic
disorders to prevent stone growth or formation of new cal-
culi. One or more metabolic abnormalities can be identiﬁed
in up to 77% of stone-forming patients [47].
Several studies endorse the role of medical treatment
after SWL, especially when residual fragments are present.
Fine et al. evaluated 80 patients who underwent a full meta-
bolic evaluation after SWL and were given selective medical
therapy [48]. Speciﬁc attention was paid to the signiﬁcance
of residual stone fragments and their eﬀect on stone growth
or recurrent stone formation during long-term followup. In
patients with residual fragments after SWL, speciﬁc medical
therapy produced an 81% stone-free rate. More than half
of the patients with residual stone fragments who were not
managed with medical therapy showed signiﬁcant stone
growth at followup. Only 16% of the same group of patients
on medical treatment demonstrated increase in stone size.
Our randomized prospective trial studied the eﬀect of
citrate therapy or conservative measures (dietary limitation
of dairy products and salty foods and increased ﬂuids)
on residual fragments 6 to 8 weeks after SWL [42]. At a
followup of 12 months, there was 75% reduction in the
clearance of calcium stone fragments in patients receiving
citrate treatment. Only 32% of the patients following con-
servative measures, however, had clearance of their calcium
stone fragments. Similarly, in patients with residual-infected
fragments, nonselective medical therapy with citrate cleared
residual fragments in 86% of the patients, whereas only 40%
ofthepatientsfollowingconservativemeasureshadclearance
of their infected fragments.
Another study evaluated the eﬀect of potassium citrate
onresidualstonefragmentsafterSWLforlowerpolecalcium
oxalate urolithiasis [49]. Four weeks after SWL, 34 patients
who had residual stones were randomly assigned to a citrate
therapy or control group (high ﬂuid intake recommended to
achieve a minimum daily urine output of 2L and avoidance
of dietary excesses). At the 12 month followup, 44.4% of
the treated patients were stone-free, whereas clearance was
obtained in only 12.5% of the control group.
A randomized study conﬁrms the eﬀectiveness of potas-
sium citrate in children with residual fragments 4 weeks after
SWL [50]. Speciﬁc attention as paid to the signiﬁcance of
residual stone fragments and their eﬀect on stone growth
or recurrence in the treated and control groups (no speciﬁc
preventive measure).
At 24.4 months of followup, children who had received
citratetreatmentshowedacceptableregrowthandrecurrence
rates (18.1%), whereas both recurrence and regrowth were
evident in most children of the control group (72.7%).
Recently, another randomized study has conﬁrmed the
preventive eﬀects of alkaline citrate on stone recurrence as
wellasstonegrowthafterSWLorpercutaneousnephrolitho-
tomy in 76 patients with calcium-containing stones [51].4 Advances in Urology
At 12 months of followup, of the residual stone group,
30.8% and 9.1% of the treated and control groups were
stone-free, respectively. Furthermore, increased stone size
was found in 7.7% and 54.5% of the treated and control
groups, respectively.
Taking these studies into account, residual fragments
pose a signiﬁcant risk for stone or recurrent stone formation.
Medical therapy, speciﬁcally alkaline citrate, reduces the rate
of stone recurrence or stone growth in patients undergoing
SWL for renal calculi. Consequently, adjuvant medical ther-
apy after SWL may actually improve stone-free rates by
encouraging fragment clearance. If this is indeed the case,
the administration of potassium citrate immediately after or
b e f o r eS W Lm a yp r o v et ob ee ﬃcacious. Interestingly, potas-
sium citrate appeared to be eﬀective in a variety of metabolic
anomalies, although stratiﬁcation of outcomes by urinary
biochemical abnormality was not performed in some studies
[52]. With further study, short- or long-term potassium
citrate treatment of patients undergoing SWL may prove
beneﬁcial.
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